Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,615.85 -68.13 -2.54%
FTSE 100 6,202.75 -146.07 -2.30%
DAX 7,995.11 -201.97 -2.46%
Ticker Volume Price Price Delta
Nikkei 13,014.60 -230.64 -1.74%
Hang Seng 20,382.90 -604.02 -2.88%
S&P/ASX 200 4,758.39 -102.99 -2.12%
  • Exchange: Dublin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Elan Corp PLC

+ Add to Watchlist

ELN:ID

10.5150 EUR 0.4050 4.01%

As of 05:35:43 ET on 06/20/2013.

Snapshot for Elan Corp PLC (ELN)

Open: 10.3500 Day's Range: 10.3500 - 10.6000 Volume: 11,132
Previous Close: 10.1100 52wk Range: 6.8290 - 11.7840 1-Yr Rtn: -5.68%

Stock Chart for ELN

No chart data available.
  • ELN:ID 10.4300
  • 1D
  • 1M
  • 1Y
10.1100
Interactive ELN Chart

Previous Close

Key Statistics for ELN

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. ISEQ -
Earnings Per Share (USD) (ttm) -0.0855
Est. EPS (USD) (12/2013) -0.1430
Est. PEG Ratio -
Market Cap (M EUR) 5,391.65
Shares Outstanding (M) 511.52
30 Day Average Volume 340,296
Price/Book (mrq) 12.0585
Price/Sale (ttm) 13.6911
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 07/25/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ELN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ELN

Elan Corporation plc is a specialty pharmaceutical company. The Group's drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan's Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.

G Kelly MartinChief Executive OfficerHans Peter HaslerChief Operating Officer
Fabiana Lacerca-AllenChief Compliance OfficerGuriq BasiChief Science & Tech Officer
More Company Profile & Key Executives for ELN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil